Microbio Industry Talk

🧫🦠🧫Calling all biotech students with a med tech major! Come learn about the revolutionising sepsis diagnostic technology, InfectID™-BSI proudly owned by the TRI-based biotech company, Microbio.🧫🦠🧫

👩‍🔬🔎👩‍🔬It all started when Dr Flavia Huygens developed and validated a process that identifies pathogens by targeting Single Nucleotide Polymorphisms (SNPs), a pathogen’s DNA ‘fingerprint’, found at a specific point in its genetic code. By focusing on SNPs rather than the whole genome, the process is fast, inexpensive, highly sensitive and can be adapted to address different target pathogens. This technology was considered a world-first and is unique in its design and application, leading to several publications.The test was refined and became InfectID™, which uses real-time PCR followed by high-resolution melt-curve analysis to identify pathogen species directly from whole blood without the need to pre-culture.👩‍🔬🔎👩‍🔬

Event Details:

Date: Wed 03/09/2025

Time: 5:45-7:30pm

Location: 63-358 - Physiology Building, UQ

Learning Outcome:

⭐️Commercialisation strategies on developing medical diagnostics

⭐️Industrial application of microbiology, biochemistry & bioinformatics

⭐️Entrepreneurial experience in developing medical diagnostics

⭐️The clinical significance of diagnostic products